World's Best Scientists 2026 revealed!
Minoru Hasegawa

Minoru Hasegawa

D-Index & Metrics

Immunology

D-Index
82
Citations
20490
World Ranking
1529
National Ranking
60

Medicine

D-Index
83
Citations
21200
World Ranking
15771
National Ranking
489

Minoru Hasegawa publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Minoru Hasegawa sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 393 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Minoru Hasegawa D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Minoru Hasegawa sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 82 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Minoru Hasegawa is affiliated with the University of Fukui in Japan. Their research primarily spans the field of Medicine, with a focus on several specialized subfields including Dermatology, Pathology and Forensic Medicine, Rheumatology, Epidemiology, and Surgery.

The scientist's work covers various main topics such as:

  • Systemic Sclerosis and Related Diseases
  • Autoimmune Bullous Skin Diseases
  • Mast cells and histamine
  • Cancer and Skin Lesions
  • Dermatologic Treatments and Research
  • Nonmelanoma Skin Cancer Studies
  • Eosinophilic Disorders and Syndromes

Minoru Hasegawa has published extensively, with notable papers including:

  • Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial, 2021, The Lancet Rheumatology
  • Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trial, 2022, The Lancet Rheumatology
  • Potential Biomarkers in Systemic Sclerosis: A Literature Review and Update, 2020, Journal of Clinical Medicine
  • Creation and Validation of Classification Criteria for Discoid Lupus Erythematosus, 2020, JAMA Dermatology
  • Pharmacological Profile of Naldemedine, a Peripherally Acting μ-Opioid Receptor Antagonist: Comparison with Naloxone and Naloxegol, 2020, Journal of Pharmacology and Experimental Therapeutics

The frequent coauthors collaborating with Hasegawa include:

  • Noritaka Oyama
  • Hiroshi Kasamatsu
  • Sei-ichiro Motegi
  • Manabu Fujimoto
  • Yoshihide Asano

Minoru Hasegawa's publications are often found in journals such as:

  • The Journal of Dermatology
  • Journal of Cutaneous Immunology and Allergy
  • Arthritis Research & Therapy
  • The Lancet Rheumatology
  • JDDG Journal der Deutschen Dermatologischen Gesellschaft

Best Publications

  • Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis.

    Hasegawa M;Fujimoto M;Kikuchi K;Takehara K

  • Quantitative Genetic Variation in CD19 Expression Correlates with Autoimmunity

    Shinichi Sato;Minoru Hasegawa;Manabu Fujimoto;Thomas F. Tedder

  • Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.

    Yasuhito Hamaguchi;Manabu Fujimoto;Takashi Matsushita;Kenzo Kaji

  • Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study.

    Yasuhito Hamaguchi;Masataka Kuwana;Kana Hoshino;Minoru Hasegawa

  • Altered blood B lymphocyte homeostasis in systemic sclerosis: Expanded naive B cells and diminished but activated memory B cells

    Shinichi Sato;Manabu Fujimoto;Minoru Hasegawa;Kazukiko Takehara

  • Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis.

    Shinichi Sato;Minoru Hasegawa;Kazuhiko Takehara

  • Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy

    K. Kaji;M. Fujimoto;M. Hasegawa;M. Kondo

  • Mouse CD20 expression and function.

    Junji Uchida;Youngkyun Lee;Minoru Hasegawa;Yinghua Liang

  • Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.

    Shinichi Sato;Tetsuya Nagaoka;Minoru Hasegawa;Takuya Tamatani

  • Elevated serum BAFF levels in patients with systemic sclerosis: Enhanced BAFF signaling in systemic sclerosis B lymphocytes

    Takashi Matsushita;Minoru Hasegawa;Koichi Yanaba;Masanari Kodera

  • CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse.

    Eriko Saito;Manabu Fujimoto;Minoru Hasegawa;Kazuhiro Komura

  • Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins.

    Manabu Fujimoto;Yasuhito Hamaguchi;Kenzo Kaji;Takashi Matsushita

  • Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy

    Yuki Ichimura;Takashi Matsushita;Yasuhito Hamaguchi;Kenzo Kaji

  • Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis.

    M Hasegawa;S Sato;K Takehara

  • CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma.

    Ayumi Yoshizaki;Yohei Iwata;Kazuhiro Komura;Fumihide Ogawa

  • Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts

    Taiji Nakashima;Masatoshi Jinnin;Keitaro Yamane;Noritoshi Honda

  • Small solitary pulmonary nodules (< or =1 cm) detected at population-based CT screening for lung cancer: Reliable high-resolution CT features of benign lesions.

    Shodayu Takashima;Shusuke Sone;Feng Li;Yuichiro Maruyama

  • Delayed Wound Healing in the Absence of Intercellular Adhesion Molecule-1 or L-Selectin Expression

    Tetsuya Nagaoka;Yuko Kaburagi;Yasuhito Hamaguchi;Minoru Hasegawa

  • B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis.

    Minoru Hasegawa;Yasuhito Hamaguchi;Koichi Yanaba;Jean-David Bouaziz

  • Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial

    Satoshi Ebata;Ayumi Yoshizaki;Koji Oba;Kosuke Kashiwabara

  • CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms.

    Jonathan C Poe;Yoko Fujimoto;Minoru Hasegawa;Minoru Hasegawa;Karen M Haas

Frequent Co-Authors

Kazuhiko Takehara
Kazuhiko Takehara Kanazawa University
Manabu Fujimoto
Manabu Fujimoto Osaka University
Shinichi Sato
Shinichi Sato University of Tokyo
Hironobu Ihn
Hironobu Ihn Kumamoto University
Koichi Yanaba
Koichi Yanaba Jikei University School of Medicine
Thomas F. Tedder
Thomas F. Tedder Duke University
Yoshihide Asano
Yoshihide Asano University of Tokyo
Masataka Kuwana
Masataka Kuwana Nippon Medical School
Osamu Ishikawa
Osamu Ishikawa Gunma University
Takafumi Kadono
Takafumi Kadono St. Marianna University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often opens doors to a variety of advanced healthcare roles. For professionals looking to expand their expertise, exploring specialized nursing programs can be highly beneficial. For instance, the cheapest online pmhnp certificate programs offer accessible pathways to become certified psychiatric mental health nurse practitioners.

Nursing professionals considering career advancement should also assess earning potential. Data on how much do dnps make provides valuable insights to guide decisions on further education and specialization.

Those who started as family nurse practitioners (FNPs) might find online fnp to acnp bridge program online options helpful for transitioning into acute care specializations, broadening their clinical scope and expertise.

Additionally, accelerated options such as accelerated rn to np programs allow registered nurses to fast-track their journey toward becoming nurse practitioners, aligning well with the dynamic demands of Immunology and related healthcare fields.

Best Scientists Citing Minoru Hasegawa

Trending Scientists

Recently Published Articles